Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Sulfo-NHS-SS-Biotin for Surface Proteomics
2026-09-08
Use Sulfo-NHS-SS-Biotin to label accessible protein amines in aqueous workflows, then exploit its cleavable disulfide linker for surface proteomics, purification, and topology-aware validation. The kit combines reversible chemistry with streptavidin capture, making it useful for both intact-cell assays and purified protein or antibody workflows.
-
STMN2 Loss in ALS: Translation and Stress Granules
2026-09-08
This reference study identifies TDP-43-independent mechanisms that deplete the neuronal protein STMN2 during acute and chronic cellular stress. By combining neuronal models, pharmacological perturbations, single-molecule analyses, and longitudinal survival measurements, it connects translation failure and stress granules to neuronal vulnerability while revealing an RNA-based compensatory response in ALS subtypes.
-
METTL17, Mitochondrial Translation, and Ferroptosis
2026-09-07
The 2024 Redox Biology study identifies METTL17 as a mitochondrial regulator of ferroptosis resistance and colorectal cancer progression. Its findings connect mitochondrial RNA methylation and translation with lipid peroxidation control, providing a mechanistic rationale for combining METTL17 suppression with ferroptosis-based strategies.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-09-07
HRP Goat Anti-Rabbit IgG (H+L) Antibody provides an enzyme-linked route for detecting rabbit IgG primary antibodies in Western blot, ELISA, IHC, and immunocytochemistry. It is intended for research workflows only; assay-specific working dilutions and performance should be established experimentally because no directly matched paper evidence or universal dilution is provided.
-
Cy5-UTP for Mechanism-Resolved RNA Imaging
2026-09-05
Cy5-UTP enables direct fluorescent RNA probe synthesis while preserving a clear path from molecular labeling to biological interpretation. This article explains how Cyanine 5-uridine triphosphate can support FISH, transcript localization, and mechanistically informed studies of RNA–protein condensates.
-
HyperFluor 488 Goat Anti-Rabbit IgG for NETosis
2026-09-04
Learn how the HyperFluor 488 Goat Anti-Rabbit IgG fluorescent antibody conjugate can support mechanism-driven imaging of NETosis and IL-36R biology. This guide connects psoriasis research findings with assay design, controls, multiplexing, and fluorescence workflow decisions.
-
Nitazoxanide Targets IMPA1-RAGE in Pulmonary Hypertension
2026-09-04
The reference study identifies IMPA1 as a direct molecular target of nitazoxanide and connects IMPA1-RAGE signaling with PI3K/Akt/mTOR activity, glycolysis, and pulmonary vascular remodeling. Its complementary animal, cellular, and target-engagement experiments support nitazoxanide as a mechanistically informed candidate for pulmonary hypertension, while leaving important questions about causality, disease-subtype relevance, and clinical translation.
-
NSC-23766: Rac GTPase Inhibitor Workflow
2026-09-03
NSC-23766 is a practical Rac GTPase inhibitor for connecting Rac1 activity with apoptosis, migration, stemness, and endothelial barrier phenotypes. This workflow shows how to optimize dosing, distinguish biochemical from cellular potency, and extend single-agent studies into BRD4–RAC1 combination experiments.
-
Tropisetron Hydrochloride Assay Workflows
2026-09-03
Tropisetron Hydrochloride supports receptor pharmacology, serotonin pathway studies, and transporter-focused renal assays in one adaptable workflow. This guide translates published OCT2/MATE1 findings into practical experiment design, controls, and troubleshooting steps for reliable in vitro data.
-
Thymoquinone Protects Against Doxorubicin Cardiotoxicity
2026-09-02
A 2025 Toxicology and Applied Pharmacology study identifies thymoquinone as a preclinical cardioprotective agent in a doxorubicin-treated mouse model. Its findings connect improved cardiac function with Nrf2/HO-1 activation, stronger antioxidant defenses, preserved mitochondria, and reduced ferroptosis-related injury.
-
6-FAM SE: Practical Fluorescent Labeling Workflows
2026-09-02
6-FAM SE combines amine-selective coupling with durable fluorescent conjugates for DNA, protein, peptide, and nanoparticle assay development. This guide turns the reagent into a practical workflow, from DMSO stock preparation and labeling to purification, quantitative QC, and careful translation into MOF-based nanomedicine studies.
-
MG-132 in Proteasome, Apoptosis, and HCMV Assays
2026-09-01
MG-132, also known as Z-LLL-al, provides a cell-permeable way to connect proteasome activity with protein turnover, apoptosis, ROS, and cell-cycle phenotypes. This workflow also shows how it can be used cautiously to test whether HCMV UL88-associated MyD88 loss is sensitive to proteasome blockade.
-
MMP-2-Responsive Liposome for Sequential Immunotherapy
2026-09-01
The reference study develops NLG919@Lip-pep1, an MMP-2-responsive liposome designed to deliver the PD-1 pathway-blocking peptide AUNP-12 before exposing a second tumor-targeting module carrying the IDO inhibitor NLG919. Its cascade-targeting strategy combines checkpoint inhibition with immunosuppressive microenvironment remodeling and improves antitumor activity in breast cancer models, while highlighting important requirements for translational nanomedicine.
-
O-GlcNAc, HUWE1, and Ferroptosis in Preeclampsia
2026-08-31
This study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links trophoblast protein modification to iron handling, ferroptosis, and syncytialization defects in preeclampsia. Its combination of placental analyses, O-GlcNAc modification proteomics, mechanistic validation, and mouse experiments provides a framework for examining how altered nutrient-sensitive signaling affects placental disease.
-
Cyclic di-GMP as an Antitoxin in Biofilm Persistence
2026-08-31
Liao et al. identify cyclic di-GMP as a small-molecule antitoxin that restrains the genotoxic toxin HipH during biofilm development. Their findings connect adhesion-stage signaling with DNA double-strand breaks, genome instability, and antibiotic persistence, providing a mechanistic framework for studying biofilm resilience.